Robinson Pharma Inc. Joins Industry Advocacy Group, The Council for Responsible Nutrition (CRN)

January 5, 2010 – Santa Ana, Ca- Robinson Pharma Inc., (RPI) announced that it has joined The Council for Responsible Nutrition (CRN) as a full voting member. CRN is the leading advocacy group for the dietary supplements industry and provides leadership on regulatory affairs, government relations, scientific issues & media relations. Robinson Pharma Inc. will contribute to the overall health and success of the dietary supplement industry through its financial support and participation in this prestigious organization.

RPI has experienced rapid growth over the past 3 years and has become a leading vendor of private label, store brand, and contract manufacturer of nutritional products serving the largest domestic retailers, marketers, and many international clients. Part of this success is a responsibility to the overall health of the dietary supplement industry and a commitment to providing support on key legislative, regulatory, scientific, and media response initiatives. Tuong Nguyen, CEO of RPI, stated, “The decision to join CRN was appropriate at this time as our company has taken a leadership role in private label manufacturing and now has the responsibility to support the overall health and sustainability of the dietary supplement category that has been so beneficial to our company. Our participation in CRN is part of our company-wide commitment to adhere to the most rigorous standards of conduct and the highest code of ethics in the industry. We feel that membership in CRN represents one of our best opportunities to demonstrate our support and commitment to participating positively with the most important companies on the key issues facing our industry.

Robinson Pharma Inc. (RPI) is a minority owned, Southern California based, drug licensed, full service provider of private label, store brand, and contract manufacturing services for dietary supplements. RPI features the largest soft gel encapsulation capacity in the U.S. with 22 continuous dry encapsulation lines capable of producing over 12 billion soft gels per year. Production capabilities include tablet compression, capsule filling, enteric coating of soft gels and tablets, custom imprinting, and a range of packaging options including bottles, blister packaging boxing, and bulk product. Additional services include product development and ingredient sourcing. Robinson Pharma Inc. provides rapid turnaround on all projects and offers highly competitive pricing. Robinson Pharma Inc. maintains 400,000 square feet of production, operations, and warehousing facilities. For more information please email [email protected], Phone (714) 241-0235 or visit

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.